Immunotherapy shows promise against lung precancer in heavy smokers
NCT ID NCT03347838
First seen Dec 15, 2025 · Last updated May 24, 2026 · Updated 15 times
Summary
This study tested whether the drug nivolumab can reverse precancerous spots in the lungs of heavy smokers or people with a history of lung or head and neck cancer. Nineteen participants received the drug to see if their lung tissue improved. The goal was to stop these spots from turning into cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOBACCO SMOKING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Denver VA Hospital
Denver, Colorado, 80220, United States
-
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.